Breast Cancer Breast cancer is the most common cancer in women worldwide, claiming the lives of hundreds of thousands of women each year. Although it’s rare, men can also be diagnosed with […]
Clarient & Health Discovery Corp.’s New Diagnostic Test For Prostate Cancer Has 97% Specificity, Study Says
ALISO VIEJO, Calif. & SAVANNAH, Ga.–(BUSINESS WIRE)–Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, and Health Discovery Corporation (HDC) (OTCBB: […]
RXi Pharma developing the next generation of immuno-oncology therapeutics
RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (sd-rxRNA®) therapeutic platform. The Company’s discovery and research efforts are focused on […]
Advances in Head and Neck Cancers
Head & Neck Cancer Report Launched The first chapter of the Cancer Impact Guide includes an overall summary of the current approach to diagnosis and standard of care and profiles of companies. […]
Cible’s smart drug platform overcomes platinum drug resistance
Cible is a preclinical-stage cancer drug company that solves the major problems of traditional cancer therapy through the implementation of a smart drug platform. The first lead candidate, oxaliTEX, is found to […]
Tosk works to alleviate the painful, debilitating, and potentially fatal side effects of front line cancer therapies
Tosk is a dynamic drug development company dedicated to alleviating the painful, debilitating, and potentially fatal side effects of front line cancer therapies and to make certain cancer drugs effective in patients […]
TargaGenix develops novel compounds that are effective on both drug-resistant tumors and cancer stem cells.
TargaGenix develops novel compounds that are effective on both drug-resistant tumors and cancer stem cells. In numerous preclinical models of cancer, including colon, pancreatic, prostate, breast and lung cancers the company’s lead […]
OTraces uses math/physics-based noise suppression techniques to enhance the accuracy and performance of cancer
OTraces has developed a disruptive technology using math/physics-based noise suppression techniques to enhance the accuracy and performance of cancer diagnostics. By using these techniques to access the active proteins found in the […]
